| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |